Global Healthcare Associated Infections Treatment Market Report By Product (Consumables, Analyzers/Instruments), By Pathogens (Viral, Bacterial, Fungal), By Treatment (Sterilization,Chemical, Radiation), By Type of Infections (Urinary Tract Infections, Surgical Site Infections, Hospital-Acquired Pneumonia, Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections, Other Healthcare-Associated Infections), By Diagnostics Test (Traditional Diagnostics, Molecular Diagnostics), By End Use (Hospitals, Clinics, ASCs, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Healthcare Associated Infections Treatment Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213243

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Healthcare Associated Infections Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Healthcare-associated infections (HAI) can be referred to as infections that are developed in hospitals, nursing homes, or other healthcare facilities during hospitalization or while receiving treatments. These infections do exist before hospital admission. Healthcare staff, nurses, patients, their relatives, and visitors are the most vulnerable people who can get affected by HAI. HAI is caused by pathogenic agents such as bacteria, viruses, and fungi. The typical HAI include pneumonia, urinary tract infection, bloodstream infections, surgical site infections, and gastrointestinal infections. HAI is described as an unnecessary burden and risk globally as a significant number of people are affected by HAI every year. The main reason for HAI is contaminated hospital equipment devices, transmission through infected people, and improper usage of antibiotics.

Market Dynamics

The treatment plan for HAI includes the use of antibiotics, antiviral and antifungal drugs, ventilators, and other therapies. The global market for HAI treatment is growing rapidly, owing to the increasing prevalence of HAI. The other factors that are contributing to the market are reduced immunity of the people, overcrowded hospitals, rapidly spreading contagious diseases, contaminated hospital devices, growing bacterial resistance to the routinely used antibiotics. During COVID-19, the global HAI treatment market is expected to increase, owing to rapidly spreading pandemic and overcrowded hospitals.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of healthcare associated infections treatment.

Market Segmentation

The entire healthcare associated infections treatment market has been sub-categorized into product, pathogens, treatment, type of infections, diagnostics test and end use. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

Consumables
Analyzers/Instruments

By Pathogens

Viral
Bacterial
Fungal

By Treatment

Sterilization
Chemical
Radiation

By Type of Infections

By Diagnostics Test

Traditional Diagnostics
Molecular Diagnostics

By End Use

Hospitals
Clinics
ASCs
Others

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for healthcare associated infections treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Healthcare Associated Infections Treatment Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the healthcare associated infections treatment market include HORIBA, Ltd., BD., bioMérieux, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience, QIAGEN, ASP, Fortive, Johnson & Johnson Services, 3M, STERIS plc., Getinge AB., Cantel Medical., Belimed, Trinity Biotech, DiaSorin, OpGen, Accelerate Diagnostics, Thermo Fisher Scientific, Bio-Rad, Luminex Corporation., Quidel Corporation. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Healthcare Associated Infections Treatment Market
       2.2. Global Healthcare Associated Infections Treatment Market Snapshot

3 . HEALTHCARE ASSOCIATED INFECTIONS TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Healthcare Associated Infections Treatment Market
       3.3. Market Restraints of Healthcare Associated Infections Treatment Market
       3.4. Opportunities of Healthcare Associated Infections Treatment Market
       3.5. Trends of Healthcare Associated Infections Treatment Market
       3.6. Porter’s Five Force Analysis of Healthcare Associated Infections Treatment Market
       3.7. Healthcare Associated Infections Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Pathogens
           3.7.3 Market Attractive Analysis by Treatment
           3.7.4 Market Attractive Analysis by Type of Infections
           3.7.5 Market Attractive Analysis by Diagnostics Test
           3.7.6 Market Attractive Analysis by End Use
           3.7.7 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Healthcare Associated Infections Treatment Value Chain Analysis
       4.2. Healthcare Associated Infections Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Healthcare Associated Infections Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Healthcare Associated Infections Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Healthcare Associated Infections Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Healthcare Associated Infections Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Healthcare Associated Infections Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Healthcare Associated Infections Treatment Market

6 . GLOBAL HEALTHCARE ASSOCIATED INFECTIONS TREATMENT MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Global Healthcare Associated Infections Treatment Market Analysis by Product
       6.3 Market Analysis of Consumables by Regions
       6.4 Market Analysis of Analyzers/Instruments by Regions

7 . GLOBAL HEALTHCARE ASSOCIATED INFECTIONS TREATMENT MARKET ANALYSIS BY PATHOGENS
       7.1 Overview by Pathogens
       7.2 Global Healthcare Associated Infections Treatment Market Analysis by Pathogens
       7.3 Market Analysis of Viral by Regions
       7.4 Market Analysis of Bacterial by Regions
       7.5 Market Analysis of Fungal by Regions

8 . GLOBAL HEALTHCARE ASSOCIATED INFECTIONS TREATMENT MARKET ANALYSIS BY TREATMENT
       8.1 Overview by Treatment
       8.2 Global Healthcare Associated Infections Treatment Market Analysis by Treatment
       8.3 Market Analysis of Sterilization by Regions
       8.4 Market Analysis of Chemical by Regions
       8.5 Market Analysis of Radiation by Regions

9 . GLOBAL HEALTHCARE ASSOCIATED INFECTIONS TREATMENT MARKET ANALYSIS BY TYPE OF INFECTIONS
       9.1 Overview by Type of Infections
       9.2 Global Healthcare Associated Infections Treatment Market Analysis by Type of Infections
       9.3 Market Analysis of Urinary Tract Infections by Regions
       9.4 Market Analysis of Surgical Site Infections by Regions
       9.5 Market Analysis of Hospital-Acquired Pneumonia by Regions
       9.6 Market Analysis of Bloodstream Infections by Regions
       9.7 Market Analysis of Gastrointestinal Infections by Regions
       9.8 Market Analysis of Respiratory Infections by Regions
       9.9 Market Analysis of Other Healthcare-Associated Infections by Regions

10 . GLOBAL HEALTHCARE ASSOCIATED INFECTIONS TREATMENT MARKET ANALYSIS BY DIAGNOSTICS TEST
       10.1 Overview by Diagnostics Test
       10.2 Global Healthcare Associated Infections Treatment Market Analysis by Diagnostics Test
       10.3 Market Analysis of Traditional Diagnostics by Regions
       10.4 Market Analysis of Molecular Diagnostics by Regions

11 . GLOBAL HEALTHCARE ASSOCIATED INFECTIONS TREATMENT MARKET ANALYSIS BY END USE
       11.1 Overview by End Use
       11.2 Global Healthcare Associated Infections Treatment Market Analysis by End Use
     11.3 Market Analysis of Hospitals by Regions
       11.4 Market Analysis of Clinics by Regions
       11.5 Market Analysis of ASCs by Regions
       11.6 Market Analysis of Others by Regions

12 . GLOBAL HEALTHCARE ASSOCIATED INFECTIONS TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       12.1. Regional Outlook
       12.2. Introduction
       12.3. North America
           12.3.1. Overview
           12.3.2. North America Healthcare Associated Infections Treatment Market Estimate By Market Segment
           12.3.3. North America Healthcare Associated Infections Treatment Market Estimate By Country
           12.3.4. United State
       12.4. Rest Of North America
           12.4.1. Europe
           12.4.2. Overview
           12.4.3. Europe Healthcare Associated Infections Treatment Market Estimate by Market Segment
           12.4.4. Europe Healthcare Associated Infections Treatment Market Estimate by Country
           12.4.5. United Kingdom
           12.4.6. France
           12.4.7 Germany
       12.5. Rest of Europe
           12.5.1. Asia Pacific
           12.5.2. Overview
           12.5.3. Asia Pacific Healthcare Associated Infections Treatment Market Estimate by Market Segment
           12.5.4. Asia Pacific Healthcare Associated Infections Treatment Market Estimate by Country
           12.5.5. China
           12.5.6. Japan
           12.5.7. India
       12.6. Rest of Asia Pacific
           12.6.1. Latin America
           12.6.2. Overview
           12.6.3. Latin America Healthcare Associated Infections Treatment Market Estimate by Market Segment
           12.6.4. Latin America Healthcare Associated Infections Treatment Market Estimate by Country
           12.6.5. Brazil
       12.7. Rest of Latin America
           12.7.1. Middle East & Africa
           12.7.2. Overview
           12.7.3. Middle East & Africa Healthcare Associated Infections Treatment Market Estimate by Market Segment
           12.7.4. Middle East & Africa Healthcare Associated Infections Treatment Market Estimate by Country
           12.7.5. Middle East
           12.7.6 Africa

13 . COMPETITIVE LANDSCAPE OF THE HEALTHCARE ASSOCIATED INFECTIONS TREATMENT COMPANIES
       13.1. Healthcare Associated Infections Treatment Market Competition
       13.2. Partnership/Collaboration/Agreement
       13.3. Merger And Acquisitions
       13.4. New Product Launch
       13.5. Other Developments

14 . COMPANY PROFILES OF HEALTHCARE ASSOCIATED INFECTIONS TREATMENT INDUSTRY
       14.1. Company Share Analysis
       14.2. Market Concentration Rate
       14.3. HORIBA, Ltd.
           14.3.1. Company Overview
           14.3.2. Financials
           14.3.3. Products
          14.3.4. Recent Developments
       14.4. BD
           14.4.1. Company Overview
           14.4.2. Financials
           14.4.3. Products
           14.4.4. Recent Developments
       14.5. bioMérieux
           14.5.1. Company Overview
           14.5.2. Financials
           14.5.3. Products
           14.5.4. Recent Developments
       14.6. Danaher
           14.6.1. Company Overview
           14.6.2. Financials
           14.6.3. Products
           14.6.4. Recent Developments
       14.7. F. Hoffmann-La Roche Ltd.
           14.7.1. Company Overview
           14.7.2. Financials
           14.7.3. Products
           14.7.4. Recent Developments
       14.8. Meridian Bioscience
           14.8.1. Company Overview
           14.8.2. Financials
           14.8.3. Products
           14.8.4. Recent Developments
       14.9. QIAGEN
           14.9.1. Company Overview
           14.9.2. Financials
           14.9.3. Products
           14.9.4. Recent Developments
       14.10. ASP
           14.10.1. Company Overview
           14.10.2. Financials
           14.10.3. Products
           14.10.4. Recent Developments
       14.11. Fortive
           14.11.1. Company Overview
           14.11.2. Financials
           14.11.3. Products
           14.11.4. Recent Developments
       14.12. Johnson & Johnson Services
           14.12.1. Company Overview
           14.12.2. Financials
           14.12.3. Products
           14.12.4. Recent Developments
       14.13. 3M
           14.13.1. Company Overview
           14.13.2. Financials
           14.13.3. Products
           14.13.4. Recent Developments
       14.14. STERIS plc
           14.14.1. Company Overview
           14.14.2. Financials
           14.14.3. Products
           14.14.4. Recent Developments
       14.15. Getinge AB
           14.15.1. Company Overview
           14.15.2. Financials
           14.15.3. Products
           14.15.4. Recent Developments
       14.16. Cantel Medical
           14.16.1. Company Overview
           14.16.2. Financials
           14.16.3. Products
           14.16.4. Recent Developments
       14.17. Belimed
           14.17.1. Company Overview
           14.17.2. Financials
           14.17.3. Products
           14.17.4. Recent Developments
       14.18. Trinity Biotech
           14.18.1. Company Overview
           14.18.2. Financials
           14.18.3. Products
           14.18.4. Recent Developments
       14.19. DiaSorin
           14.19.1. Company Overview
           14.19.2. Financials
           14.19.3. Products
           14.19.4. Recent Developments
       14.20. OpGen
           14.20.1. Company Overview
           14.20.2. Financials
           14.20.3. Products
           14.20.4. Recent Developments
       14.21. Accelerate Diagnostics
           14.21.1. Company Overview
           14.21.2. Financials
           14.21.3. Products
           14.21.4. Recent Developments
       14.22. Thermo Fisher Scientific
           14.22.1. Company Overview
           14.22.2. Financials
           14.22.3. Products
           14.22.4. Recent Developments
       14.23. Bio-Rad
           14.23.1. Company Overview
           14.23.2. Financials
           14.23.3. Products
           14.23.4. Recent Developments
       14.24. Luminex Corporation
           14.24.1. Company Overview
           14.24.2. Financials
           14.24.3. Products
           14.24.4. Recent Developments
       14.25. Quidel Corporation
           14.25.1. Company Overview
           14.25.2. Financials
           14.25.3. Products
           14.25.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "